MedTrace Logo

Validation of Combined PET-MR Quantitative Parameters for Cardiac Applications

NCT02062008 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2021-06-16

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to understand how simultaneous PET/MR acquisition can provide novel qualitative and quantitative biomarkers to guide clinical intervention and predict prognosis of patients with cardiovascular disease.

Conditions

  • Cardiac Disease

Interventions

DEVICE

PET-MRI

PET-MRI with intravenous Gadolinium and FDG. The entire study will take approximately one hour.

Sponsors & Collaborators

Principal Investigators

  • Karen G Ordovas, MD,MAS · Assistent Professor

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2018-02-10
Completion
2018-02-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02062008 on ClinicalTrials.gov